Fair Value Measurements - Warrants (Details) - USD ($) $ in Thousands |
2 Months Ended | 3 Months Ended | 9 Months Ended | |
---|---|---|---|---|
Oct. 21, 2016 |
Dec. 31, 2016 |
Dec. 31, 2016 |
Dec. 31, 2016 |
|
Fair Value Measurements | ||||
Change in fair value of warrant liability | $ 1,777 | $ 1,777 | ||
Series A Warrant | ||||
Fair Value Measurements | ||||
Fair value of warrants issued | $ 4,200 | 4,240 | ||
Change in fair value of warrant liability | $ 1,800 | $ (1,777) | ||
Series A Warrant | Maximum | ||||
Fair Value Measurements | ||||
Risk-free interest rates range (as a percent) | 2.00% | |||
Contractual term | 5 years 6 months | |||
Expected volatility range (as a percent) | 69.10% | |||
Series A Warrant | Minimum | ||||
Fair Value Measurements | ||||
Risk-free interest rates range (as a percent) | 1.30% | |||
Contractual term | 5 years 3 months 18 days | |||
Expected volatility range (as a percent) | 68.50% |
X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Risk-free interest rate assumption used in valuing an instrument. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|